Clinical Trial: CYP2D6 Related Dose Escalation of Tamoxifen in Breast Cancer Patients With Iranian Ethnic Background Resulted in Increased Concentrations of Tamoxifen and Its Metabolites

Khalaj, Zahra; Baratieh, Zohreh; Nikpour, Parvaneh; Schwab, Matthias; Schaeffeler, Elke; Mokarian, Fariborz; Khanahmad, Hossein; Salehi, Rasoul; Muerdter, Thomas E.; Salehi, Mansoor

dc.contributor.author	Schwab, Matthias
dc.contributor.author	Schäffeler, Elke
dc.contributor.author	Mürdter, Thomas E.
dc.date.accessioned	2020-05-05T12:36:32Z
dc.date.available	2020-05-05T12:36:32Z
dc.date.issued	2019
dc.identifier.issn	1663-9812
dc.identifier.uri	http://hdl.handle.net/10900/100237
dc.language.iso	en	en
dc.publisher	Frontiers Media Sa	de_DE
dc.relation.uri	http://dx.doi.org/10.3389/fphar.2019.00530	de_DE
dc.subject.ddc	610	de_DE
dc.title	Clinical Trial: CYP2D6 Related Dose Escalation of Tamoxifen in Breast Cancer Patients With Iranian Ethnic Background Resulted in Increased Concentrations of Tamoxifen and Its Metabolites	de_DE
dc.type	Article	de_DE
utue.quellen.id	20190926111821_01315
utue.personen.roh	Khalaj, Zahra
utue.personen.roh	Baratieh, Zohreh
utue.personen.roh	Nikpour, Parvaneh
utue.personen.roh	Schwab, Matthias
utue.personen.roh	Schaeffeler, Elke
utue.personen.roh	Mokarian, Fariborz
utue.personen.roh	Khanahmad, Hossein
utue.personen.roh	Salehi, Rasoul
utue.personen.roh	Muerdter, Thomas E.
utue.personen.roh	Salehi, Mansoor
dcterms.isPartOf.ZSTitelID	Frontiers in Pharmacology	de_DE
dcterms.isPartOf.ZS-Issue	Article 530	de_DE
dcterms.isPartOf.ZS-Volume	10	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE